Skip to main content

Table 1 Characteristics of patients in subgroups of accurate-T-staging, over-T-staging and under-T-staging

From: Risk factor analysis for inaccurate pre-operative MRI staging in rectal cancer

Characteristics

Total

Accurate-T-staging

Over-T-staging

Under-T-staging

P Value

Cases

551

392 (69.6%)

109 (19.4%)

50 (8.9%)

 

Gender

    

0.633

 Female

233 (42.3%)

169 (43.1%)

46 (42.2%)

18 (36%)

 

 Male

318 (57.7%)

223 (56.9%)

63 (57.8%)

32 (64%)

 

Age

59.7 ± 13.4

60.2 ± 12.9

57.3 ± 14.4

61.3 ± 14.4

0.102

BMI

22.5 ± 4.19

22.5 ± 4.4

22.5 ± 3.8

22.5 ± 3.4

0.998

Diabetes Mellitus

    

0.157

 No

507 (93.9%)

360 (93%)

99 (94.3%)

48 (100%)

 

 Yes

33 (6.1%)

27 (7%)

6 (5.7%)

0 (0%)

 

CEA

2.73 (0–255)

2.7 (0–255)

2.7 (0–197)

4.5 (1–81)

0.62

CA199

10.2 (0–2188)

10.64 (0–2188)

7.59 (0–1156)

10.35 (0–117)

0.001

Bowel Obstruction

    

0.008

 No

471 (87.5%)

350 (89.7%)

88 (79.3%)

44 (89.8%)

 

 Yes

67 (12.5%)

40 (10.3%)

23 (20.7%)

5 (10.2%)

 

WBC

6.53 ± 1.93

6.54 ± 1.91

6.53 ± 2.11

6.48 ± 1.71

0.984

HB

124.3 ± 21.5

125.0 ± 19.5

123.4 ± 24.4

121.1 ± 28.7

0.433

PLT

234.5 ± 78.4

237.6 ± 80.1

227.2 ± 74.5

226.4 ± 72.7

0.355

ALB

41.5 ± 6.30

41.6 ± 6.10

40.8 ± 6.96

42.2 ± 6.37

0.381

Tumor Location

    

0.186

 Upper

217 (39.4%)

163 (41.6%)

37 (33.9%)

17 (34%)

 

 Middle

141 (25.6%)

101 (25.8%)

24 (22%)

16 (32%)

 

 Low

193 (35%)

128 (32.7%)

48 (44%)

17 (34%)

 

Tumor Size (cm)

4.07 ± 1.69

4.22 ± 1.70

3.76 ± 1.70

3.60 ± 1.37

0.005*

Histological Subtype

    

1

 Classic Adenocarcinoma

505 (92%)

359 (92.1%)

100 (91.7%)

46 (92%)

 

 Mucinous Adenocarcinoma

44 (8%)

31 (7.9%)

9 (8.3%)

4 (8%)

 

Differentiation

    

0.824

 Grade 1/2

471 (92.4%)

337 (92.1%)

91 (94.8%)

43 (89.6%)

 

 Grade 3/4

39 (7.6%)

29 (7.9%)

5 (5.2%)

5 (10.4%)

 

MMR Status

    

0.823

 pMMR

350 (94.1%)

17 (6.6%)

4 (4.8%)

1 (3.1%)

 

 dMMR

22 (5.9%)

239 (93.4%)

80 (95.2%)

31 (96.9%)

 

Ras Mutation

    

0.322

 No

496 (90%)

355 (90.6%)

99 (90.8%)

42 (84%)

 

 Yes

55 (10%)

37 (9.4%)

10 (9.2%)

8 (16%)

 
  1. Abbreviations: BMI body mass index, CEA carcinoembryonic antigen, WBC white blood cell, HB hemoglobin, PLT plate, ALB albumin, pMMR mismatch repair-proficient, dMMR mismatch repair-deficient
  2. *Post Hoc Test: Accurate-T-staging vs over-T-staging, P = 0.012; Accurate-T-staging vs under-T-staging, P = 0.015